Vanguard Fiduciary Trust
VTVT icon

Vanguard Fiduciary Trust’s vTv Therapeutics VTVT Stock Holding History

Vanguard Fiduciary Trust’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$611K Buy
16,239
+113
+0.7% +$3.92K ﹤0.01% 3206
2026
Q1 		$640K Buy
+16,126
New +$585K ﹤0.01% 3131

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust's VTVT Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its vTv Therapeutics (VTVT) stake by 0.7% in Q2 2026, buying an estimated $3.92K and bringing the position to 16,239 shares worth $611K. The position accounts for ﹤0.01% of the portfolio, ranked #3206.

Vanguard Fiduciary Trust first reported a position in VTVT in Q1 2026 and has held it in 2 quarters since. The position peaked at $640K in Q1 2026. 45 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Vanguard Fiduciary Trust held 16,239 shares of vTv Therapeutics worth $611K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 113 vTv Therapeutics shares in Q2 2026, an estimated $3.92K.
  • vTv Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3206 holding.
  • Vanguard Fiduciary Trust first reported a position in vTv Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's vTv Therapeutics position peaked at $640K in Q1 2026.
  • 45 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.